These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4040446)

  • 1. Expression of MHC class II antigens on bile duct epithelium in experimental graft versus host disease.
    Takács L; Szende B; Rot A; Diamanstein T
    Clin Exp Immunol; 1985 Jun; 60(3):449-56. PubMed ID: 4040446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that nonlymphoid tissue injury in acute graft-versus-host disease is limited to epithelial cells aberrantly expressing MHC antigens.
    Parfrey NA; Ste-Croix H; Prud'Homme GJ
    Transplantation; 1989 Oct; 48(4):655-60. PubMed ID: 2799919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation.
    Miglio F; Pignatelli M; Mazzeo V; Baraldini M; Stefanini GF; Guardigli G; Bandini G; Ricci P; Tura S; Gasbarrini G
    J Hepatol; 1987 Oct; 5(2):182-9. PubMed ID: 3320179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early induction of MHC antigens in human liver grafts. An immunohistologic study.
    Gouw AS; Huitema S; Grond J; Slooff MJ; Klompmaker IJ; Gips CH; Poppema S
    Am J Pathol; 1988 Oct; 133(1):82-94. PubMed ID: 3052095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological changes of bile duct in experimental graft-versus-disease across minor histocompatibility barriers. III. Immunoelectron microscopic observations.
    Nonomura A; Yoshida K; Kono N; Nakanuma Y; Ohta G
    Acta Pathol Jpn; 1988 Mar; 38(3):269-80. PubMed ID: 2969170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of class I and class II major histocompatibility complex antigens (MHC) in rejecting human liver grafts.
    Gridelli B; Colledan M; Grendele M; Rossi G; Fassati LR; Galmarini D; Lazzaro A; Malavasi F; Ippoliti G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2215-6. PubMed ID: 2652715
    [No Abstract]   [Full Text] [Related]  

  • 9. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
    Hreha G; Jefferson DM; Yu CH; Grubman SA; Alsabeh R; Geller SA; Vierling JM
    Hepatology; 1999 Aug; 30(2):358-71. PubMed ID: 10421641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistological study of human hepatic graft-versus-host disease.
    Dilly SA; Sloane JP
    Clin Exp Immunol; 1985 Dec; 62(3):545-53. PubMed ID: 3910317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.
    Saitoh T; Fujiwara M; Nomoto M; Kamimura T; Ishihara K; Asakura H
    Am J Pathol; 1989 Aug; 135(2):301-7. PubMed ID: 2782375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
    Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL
    Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex expression in muscle of rats with graft-versus-host disease.
    Ohba Y; Fujikura Y; Sawada T; Tokuda N; Morimatsu M; Fukumoto T
    Histol Histopathol; 1996 Jan; 11(1):97-102. PubMed ID: 8720452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
    Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
    Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma gene expression during acute graft-versus-host disease: relationship to MHC induction and tissue injury.
    Parfrey NA; El-Sheikh A; Monckton EA; Cockfield SM; Halloran PF; Linetsky E
    J Pathol; 1999 Sep; 189(1):99-104. PubMed ID: 10451495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-mediated cholangiopathy in the murine model of graft versus host disease.
    Ueno Y; Ishii M; Yahagi K; Mano Y; Kisara N; Nakamura N; Shimosegawa T; Toyota T; Nagata S
    Hepatology; 2000 Apr; 31(4):966-74. PubMed ID: 10733554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
    El-Hayek JM; Rogers TE; Brown GR
    J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR expression in bile duct damage in hepatitis C.
    Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
    Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.